Overview

Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI

Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare aspirin/acetylsalicylic acid+ clopidogrel with aspirin/acetylsalicylic acid alone as antithrombotic treatment following TAVI for the prevention of major ischemic events (MI, ischemic stroke) or death without increasing the risk of major bleeding events.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Treatments:
Aspirin
Clopidogrel
Ticlopidine
Criteria
Inclusion Criteria:

- Patients undergoing a TAVI procedure with the Edwards valve.

Exclusion Criteria:

- Need for chronic anticoagulation treatment

- Major bleeding within the 3 months prior to the TAVI procedure

- Prior intracranial bleeding

- Drug-eluting stent implantation within the year prior to the TAVI procedure

- Allergy to clopidogrel and/or aspirin/acetylsalicylic acid